BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19350235)

  • 21. FDG uptake in lymph-nodes of HIV+ and tuberculosis patients: implications for cancer staging.
    Sathekge M; Maes A; Kgomo M; Pottel H; Stolz A; Van De Wiele C
    Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):698-703. PubMed ID: 21150859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of silent myocardial ischemia during the staging of HIV-associated lymphoma with FDG PET/CT.
    Mariano-Goulart D; Ilonca D; Bourdon A
    Clin Nucl Med; 2009 Oct; 34(10):731-3. PubMed ID: 19893417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.
    Brust D; Polis M; Davey R; Hahn B; Bacharach S; Whatley M; Fauci AS; Carrasquillo JA
    AIDS; 2006 Feb; 20(4):495-503. PubMed ID: 16470113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging studies of the HIV-infected brain.
    Chang L; Shukla DK
    Handb Clin Neurol; 2018; 152():229-264. PubMed ID: 29604980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection.
    Okosun J; Warbey V; Shaw K; Montoto S; Fields P; Marcus R; Virchis A; McNamara C; Bower M; Cwynarski K
    AIDS; 2012 Apr; 26(7):861-5. PubMed ID: 22333746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients.
    Andersen AB; Law I; Krabbe KS; Bruunsgaard H; Ostrowski SR; Ullum H; Højgaard L; Lebech A; Gerstoft J; Kjaer A
    J Neuroinflammation; 2010 Feb; 7():13. PubMed ID: 20152054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.
    Brust D; Polis M; Davey R; Hahn B; Bacharach S; Whatley M; Fauci AS; Carrasquillo JA
    AIDS; 2006 Apr; 20(7):985-93. PubMed ID: 16603850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anatomical loci of HIV-associated immune activation and association with viraemia.
    Iyengar S; Chin B; Margolick JB; Sabundayo BP; Schwartz DH
    Lancet; 2003 Sep; 362(9388):945-50. PubMed ID: 14511927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PET/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loads.
    Goshen E; Davidson T; Avigdor A; Zwas TS; Levy I
    Clin Nucl Med; 2008 Sep; 33(9):610-4. PubMed ID: 18716509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of FDG-PETCT and magnetic resonance spectroscopy in differentiating between cerebral lymphoma and non-malignant CNS lesions in HIV-infected patients.
    Westwood TD; Hogan C; Julyan PJ; Coutts G; Bonington S; Carrington B; Taylor B; Khoo S; Bonington A
    Eur J Radiol; 2013 Aug; 82(8):e374-9. PubMed ID: 23578921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tau Positron Emission Tomography Binding Is Not Elevated in HIV-Infected Individuals.
    Cooley SA; Strain JF; Beaumont H; Boerwinkle AH; Doyle J; Morris JC; Benzinger TL; Ances BM
    J Infect Dis; 2019 Jun; 220(1):68-72. PubMed ID: 30561665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lipodystrophy and echographic hepatic steatosis in HIV-positive patients under highly active antiretroviral therapy (HAART) in Yaounde (Cameroon)].
    Ongolo-Zogo P; Nkodo Mbia N; Mvogo Minkala TL; Biwole Sida M; Kouanfack C; Nko Amvene S
    Bull Soc Pathol Exot; 2012 Dec; 105(5):353-60. PubMed ID: 22886433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co-infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplant.
    Longhitano A; Alipour R; Khot A; Bajel A; Antippa P; Slavin M; Thursky K
    Transpl Infect Dis; 2021 Jun; 23(3):e13547. PubMed ID: 33338319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-2-fluoro-2-deoxyglucose uptake in white adipose tissue on pediatric oncologic positron emission tomography (PET)/computed tomography (CT).
    Wong KK; Sedig LK; Bloom DA; Hutchinson RJ; Shulkin BL
    Pediatr Radiol; 2020 Apr; 50(4):524-533. PubMed ID: 31776602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seeing Is Believing: Nuclear Imaging of HIV Persistence.
    Henrich TJ; Hsue PY; VanBrocklin H
    Front Immunol; 2019; 10():2077. PubMed ID: 31572355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia.
    Rottenberg DA; Sidtis JJ; Strother SC; Schaper KA; Anderson JR; Nelson MJ; Price RW
    J Nucl Med; 1996 Jul; 37(7):1133-41. PubMed ID: 8965184
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Jain L; Mackenzie S; Bomanji JB; Shortman R; Noursadeghi M; Edwards SG; Miller RF
    Int J STD AIDS; 2018 Jun; 29(7):691-694. PubMed ID: 29198183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain PET Imaging: Value for Understanding the Pathophysiology of HIV-associated Neurocognitive Disorder (HAND).
    Sinharay S; Hammoud DA
    Curr HIV/AIDS Rep; 2019 Feb; 16(1):66-75. PubMed ID: 30778853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HAART and Mycobacterium avium complex in an HIV infected patient with severe factor VII deficiency.
    Girmenia C; Martino P; Mazzucconi MG; Bizzoni L; Cassone A
    Haemophilia; 2000 Mar; 6(2):116-7. PubMed ID: 10781200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.